Cancer

News

Digital tech crucial to success of cancer cell therapy - Nov...

Novartis CEO Vas Narasimhan has made use of digital technology to support patients taking the company’s medicines a priority.

News

Novartis focusing on cutting CAR-T costs ahead of EU launche...

Novartis is focusing on cutting manufacturing costs for its CAR-T cancer cell therapy as the company launches it across Europe, while keeping a watching brief on ‘off-the-shelf’ therapies t

News

Known as Cabometyx in the US, the drug is licensed by Ipsen from Exelixis

EU approves Ipsen's Cabometyx in second line liver cancer

The European Commission has approved Ipsen’s Cabometyx for liver cancer, in adults previously treated with Bayer’s Nexavar.

News

Blueprint eyes quick filing for GIST drug avapritinib

Blueprint Medicines has new data for its lead cancer drug avapritinib in gastrointestinal stromal tumours (GIST) that set it on course for regulatory filings – and a close race to market wi

News

AstraZeneca's immunotherapy fails in key lung cancer trial

AstraZeneca’s immunotherapy combination including its checkpoint inhibitor drug Imfinzi has failed to improve overall survival in a first-line lung cancer trial – an indication where Merck

Views & Analysis